IP Library Granted Patent US 9,051,346
Granted Patent B2
US 9,051,346 · App. 13/699,020 · Granted Jun 9, 2015

Process for preparing triazole-containing ketolide antibiotics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,051,346
App. No.
13/699,020
Granted
Jun 9, 2015
Kind
B2
Abstract

The invention described herein pertains to processes for the preparation of macrolide antibacterial agents. In particular, the invention pertains to processes for preparing macrolides and ketolides from erythromycin A.

Claims (53)

1. A process comprising (a) the step of contacting a compound of formula (III)

or a salt thereof, wherein Q in combination with the oxime oxygen forms an acetal or ketal, with an acylating agent to form a compound of formula (IV)

or a salt thereof, wherein R is an acyl group; or

(b) the step of contacting a compound of formula (IV), or a salt thereof, with a methylating agent, to form a compound of formula (V)

or a salt thereof; or

(c) the step of contacting a compound of formula (V), or a salt thereof, with a deoximating agent to form a compound of formula (II)

or a salt thereof; or

(d) any combination of (a), (b), and (c).

2. The process of claim 1 comprising (a) and (b).

3. The process of claim 1 comprising (a) and (c).

4. The process of claim 1 comprising (b) and (c).

5. The process of claim 1 comprising (a), (b), and (c).

6. A process for preparing a compound of formula (II)

or a salt thereof, wherein:

R is an acyl group;

the process comprising (c) the step of contacting a compound of formula (V)

or a salt thereof, with a deoximating agent to form the compound of formula (II).

7. The process of claim 6 further comprising (b) the step of contacting a compound of formula (IV)

or a salt thereof, wherein R is an acyl group, with a methylating agent, to form a compound of formula (V)

or a salt thereof.

8. The process of claim 7 further comprising (a) the step of contacting a compound of formula (III)

or a salt thereof, wherein Q in combination with the oxime oxygen forms an acetal or ketal, with an acylating agent to form a compound of formula (IV)

or a salt thereof, wherein R is an acyl group.

9. The process of claim 6 comprising (a) the step of contacting a compound of formula (III)

or a salt thereof, wherein Q in combination with the oxime oxygen forms an acetal or ketal, with an acylating agent to form a compound of formula (IV)

or a salt thereof, wherein R is an acyl group(b) and (c).

10. A compound of formula (IV) or (V)

or an acid addition salt thereof, wherein Q in combination with the oxime oxygen forms an acetal or ketal, and R is an acyl group.

11. The compound of claim 10 wherein Q is 2-methoxy-2-propyl, 1-methoxycyclohexyl or 1-isopropoxycyclohexyl.

12. The compound of claim 10 wherein Q is 2-methoxy-2-propyl.

13. The compound of claim 10 wherein R is a sterically hindered acyl group.

14. The compound of claim 10 wherein R is benzoyl.

15. The process of claim 1 wherein the acylating agent is the anhydride.

16. The process of claim 1 wherein the methylating agent in step (b) is methyl bromide, methyl iodide, dimethyl sulfate, methyl p-toluenesulfonate or methyl methanesulfonate.

17. The process of claim 1 wherein the deoximating agent in step (c) comprises a reducing agent.

18. The process of claim 1 wherein the deoximating agent in step (c) comprises formic acid and sodium metabisulfite.

19. The process of claim 1 wherein Q is 2-methoxy-2-propyl, 1-methoxycyclohexyl or 1-isopropoxycyclohexyl.

20. The process of claim 1 wherein Q is 2-methoxy-2-propyl.

21. The process of claim 1 wherein R is benzoyl.

22. The process of claim 6 wherein the acylating agent is the anhydride.

23. The process of claim 6 wherein the methylating agent in step (b) is methyl bromide, methyl iodide, dimethyl sulfate, methyl p-toluenesulfonate or methyl methanesulfonate.

24. The process of claim 6 wherein the deoximating agent in step (c) comprises formic acid and sodium metabisulfite.

25. The process of claim 6 wherein Q is 2-methoxy-2-propyl, 1-methoxycyclohexyl or 1-isopropoxycyclohexyl.

26. The process of claim 6 wherein Q is 2-methoxy-2-propyl.

27. The process of claim 6 wherein R is benzoyl.

28. The compound of claim 10 of formula (IV), or a salt thereof.

29. The compound of claim 28 wherein Q is 2-methoxy-2-propyl.

30. The compound of claim 28 wherein R is benzoyl.

31. The compound of claim 28 wherein Q is 2-methoxy-2-propyl, 1-methoxycyclohexyl or 1-isopropoxycyclohexyl; and R is benzoyl.

32. The compound of claim 10 of formula (V), or a salt thereof.

33. The compound of claim 32 wherein Q is 2-methoxy-2-propyl.

34. The compound of claim 32 wherein R is benzoyl.

35. The compound of claim 32 wherein Q is 2-methoxy-2-propyl, 1-methoxycyclohexyl or 1-isopropoxycyclohexyl; and R is benzoyl.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2019
From: CEMPRA PHARMACEUTICALS, INC.
To: TETARD, INC.
Reel/Frame 050056/0731 →
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2019
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: CEMPRA PHARMACEUTICALS, INC.
Reel/Frame 049363/0706 →
SECURITY INTEREST Recorded Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →